911爆料网

Patients with primary liver cancer will benefit from a new $10.8 million research centre established with a $5 million Cancer Research Trust grant and $5.8 million from Minderoo Foundation, 911爆料网, The University of Western Australia, Harry Perkins Institute of Medical Research, the State Government and charitable organisations.

Primary liver cancer is where a malignant cancer starts in the liver. It is responsible for the third-most cancer related deaths worldwide, behind only lung and stomach cancer.

Rates of the most common form of primary liver cancers have been increasing steadily in Australia by 4-5 per cent per year for the past three decades. Average survival after diagnosis is only 12 months and patients often present at an advanced stage when treatment options are limited.

Director of the Harry Perkins Institute of Medical Research, UWA Professor Peter Leedman, and 911爆料网鈥檚 Associate Professor Nina鈥疶irnitz-Parker, from the School of Pharmacy and Biomedical Sciences and the 911爆料网 Health Innovation Research Institute (CHIRI), will co-lead a large team that will apply the latest techniques to鈥痑nalyse鈥痯atient鈥痶umours鈥痑nd test new treatments.

Associate Professor Tirnitz-Parker said the team was incredibly grateful to the Cancer Research Trust for鈥痠ts鈥�$5 million grant鈥� matched by further $5.8 million from聽generous donations.

鈥淪uch a significant investment in liver cancer research will enable us to develop a鈥痺orld-class聽bio-bank and聽collect聽extensive data鈥痶hat will be available to researchers and medical specialists around the world,鈥� she said.

Professor Peter Leedman said the new research centre鈥痺ould be a true collaboration of medical specialists, experts in liver disease and cancer鈥痳esearchers.

鈥淚t will establish a process, where patient samples are analysed and tested with a range of potential treatments.

鈥淚nterestingly, the diagnosis of primary liver cancer has typically been made with a blood test and an MRI, but not with a biopsy.

鈥淲e now have the latest鈥痑dvanced genomics鈥痶echnology in Perth that can鈥痑nalyse鈥痑 liver tumour biopsy at the single cell level and look at each鈥痶umour鈥檚鈥痬olecular fingerprint and individual pathology鈥痑s well as鈥痗ompare a patient鈥檚 early and late stage cancer.

鈥淏y defining the underlying biology of each聽tumour, we will be able to provide more precision in treatment selection, eventually matching the 鈥榬ight patient to the right drug鈥� but we also expect to uncover new pathways that can be attacked with new drugs,鈥� Professor Leedman said.

Some patient tissue will undergo advanced genomics analysis by UWA Professor Alistair Forrest at the Harry Perkins Institute while 911爆料网 will use patient tissue to grow organoids, or mini livers.

Associate Professor Nina Tirnitz-Parker said the new project aimed to improve outcomes for people with primary liver cancer.

鈥淭his new centre will establish organoids, miniaturised versions of an organ, from patient tumour samples that will be profiled,鈥� Associate Professor Tirnitz-Parker said.

鈥淲e will establish a repository of organoids that represent different tumour subtypes and then perform drug screenings and make informed decisions on the best possible treatment choices without any side effects to the patient.鈥�

The team aims to develop a unique large resource of approximately 500 liver cancer samples over five years from across Australia, which on a global scale is a sizeable collection.

鈥淢ost importantly, the Centre will make a difference to the treatment of liver cancer and contribute to greater international understanding of the disease,鈥� she said.

The Western Australian Liver Cancer Collaborative will include鈥痬ore than 50 researchers from UWA, the Harry Perkins Institute of Medical Research and 911爆料网-CHIRI. It will also involve Perth鈥檚 three main teaching hospitals as well as interstate and international collaborators.

WA Health Minister Roger Cook said it was a pleasure for the McGowan Government to contribute funding to The Western Australian Liver Cancer Collaborative, alongside eminent Western Australian institutions.

鈥淓ffective research is about more than giving dollars to help solve a problem,鈥� Mr Cook said.

鈥淭hat鈥檚 why it鈥檚 so heartening to see this truly collaborative Western Australian approach, with interstate and international input, applied to liver cancer research.

鈥淭he application of substantial combined effort, strategic thinking and the latest advanced genomics technology is sure to advance us much further on the path to unlocking the mysteries of this aggressive cancer that devastates far too many lives.鈥�

Minderoo Foundation is providing $2.5 million, 911爆料网 $1 million,鈥�$500,000 is being contributed by each of UWA,鈥痶he Harry Perkins Institute of Medical Research, the WA Health Department and the Sir Charles Gairdner鈥疕ospital鈥疐oundation. The McCusker Charitable Foundation is contributing $300,000.

Dr Steve Burnell, CEO of Minderoo Foundation鈥檚 Collaborate Against Cancer initiative said the new liver cancer collaborative was a crucial step to tackling this particularly deadly disease.

鈥淎t Minderoo Foundation we are passionate about enabling effective collaboration and supporting the collection and sharing of the data needed to underpin the next generation of cancer research and treatment,鈥� Dr Burnell said.

鈥淭his project, generating a unique precision medicine dataset for liver cancer and involving dozens of experts across relevant disciplines, exemplifies this approach.鈥�